PhillyPharma Archive: September, 2012

Lower costs will prompt more people to take their medicine, study says

Comment icon 0 Comments
A new study from the Annals of Internal Medicine says cheaper drugs would help reduce the problem of people not actually taking - or refilling... Read more

ViroPharma to add 151 jobs in Exton

Comment icon 0 Comments
As Inquirer colleague Linda Loyd wrote (link here), ViroPharma plans to double its space in Exton in Chester County and create 151 new jobs... Read more

Johnson & Johnson settles on first day of Philly Risperdal trial

Comment icon 0 Comments
A jury was picked and the trial was about to begin Monday morning in Philadelphia Common Pleas Court when Johnson & Johnson's Janssen Pharmaceuticals... Read more

Allergan: Wrinkles and New Jersey

Comment icon 0 Comments
Allergan makes glaucoma drugs that are supposed to help the inside of eyes, but it is most famous for fixing the wrinkles around them with... Read more

GSK takeover means job cuts at Human Genome Sciences

Comment icon 0 Comments
With employment numbers making news, a smaller slice of figures emerged Thursday that reminds everybody that job destruction happens when a... Read more

Analyst: Teva still formulating plans

Comment icon 0 Comments
Bernstein Research analyst Ronny Gal told clients that Teva leaders perhaps will invest more in developing current pharmaceutical assets, coordinate... Read more

J&J loses in Louisiana court of appeals, plans further fight

Comment icon 0 Comments
The only thing positive that Johnson & Johnson could take from Friday's decision by a three-judge panel of the Louisiana court of appeals... Read more

Valeant buys Medicis for $2.6 billion

Comment icon 0 Comments
Valeant Pharmaceuticals International, Inc., which tried very hard to buy Frazer-based Cephalon before Teva Pharmaceuticals won the bidding... Read more